AU2001284057A1 - Combination of lipoic acids and conjugated acids for treating diabetic disorders - Google Patents
Combination of lipoic acids and conjugated acids for treating diabetic disordersInfo
- Publication number
- AU2001284057A1 AU2001284057A1 AU2001284057A AU8405701A AU2001284057A1 AU 2001284057 A1 AU2001284057 A1 AU 2001284057A1 AU 2001284057 A AU2001284057 A AU 2001284057A AU 8405701 A AU8405701 A AU 8405701A AU 2001284057 A1 AU2001284057 A1 AU 2001284057A1
- Authority
- AU
- Australia
- Prior art keywords
- acids
- combination
- diabetic disorders
- lipoic
- treating diabetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the use of lipoic acid, a physiologically acceptable derivative or salt thereof and one compound of the formula I H3C-(CH2)n1-(CH=CH)n3-(CH2)n2-COOH I in which n1, n2 have, independently of one another, the value of an integer from 3 to 9, n3 has the value of an integer from 2 to 6, and the number of carbon atoms is 18, 20 or 22, a physiologically acceptable derivative or salt thereof, for nutritional supplementation, in functional foods and for therapeutic purposes in the treatment of diabetic disorders. Compositions having a corresponding active ingredient combination, and compositions in the form of commercial packs with corresponding combination products or single-drug products for combined use are also described.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10045059A DE10045059A1 (en) | 2000-09-12 | 2000-09-12 | Therapeutic combination of lipoic acid and conjugate acids for the treatment of diabetic disorders |
DE10045059.8 | 2000-09-12 | ||
PCT/EP2001/010501 WO2002022111A2 (en) | 2000-09-12 | 2001-09-11 | Combination of lipoic acids and conjugated acids for treating diabetic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001284057A1 true AU2001284057A1 (en) | 2002-03-26 |
Family
ID=7655916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001284057A Abandoned AU2001284057A1 (en) | 2000-09-12 | 2001-09-11 | Combination of lipoic acids and conjugated acids for treating diabetic disorders |
Country Status (10)
Country | Link |
---|---|
US (1) | US20030187058A1 (en) |
EP (1) | EP1317264B1 (en) |
JP (1) | JP2004508399A (en) |
CN (1) | CN1216602C (en) |
AT (1) | ATE271866T1 (en) |
AU (1) | AU2001284057A1 (en) |
DE (2) | DE10045059A1 (en) |
DK (1) | DK1317264T3 (en) |
ES (1) | ES2225593T3 (en) |
WO (1) | WO2002022111A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8147816B2 (en) * | 2000-08-16 | 2012-04-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
US7914815B2 (en) * | 2000-08-16 | 2011-03-29 | Encore Health, Llc | Method for delivery of pharmaceuticals for treating or preventing presbyopia |
US8697109B2 (en) * | 2000-08-16 | 2014-04-15 | Encore Health, Llc | Caged mercaptan and seleno-mercaptan compounds and methods of using them |
US8647612B2 (en) * | 2008-03-05 | 2014-02-11 | Encore Health, Llc | Dithiol compounds, derivatives, and treatment of presbyopia |
US20050112113A1 (en) * | 2000-08-16 | 2005-05-26 | Till Jonathan S. | Presbyopia treatment by lens alteration |
US7935332B2 (en) * | 2000-08-16 | 2011-05-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
EP1570752B1 (en) * | 2004-03-06 | 2008-07-02 | Cognis IP Management GmbH | Verwendung von ungesättigten Fettsäuren zur Verringerung des Appetits oder der Essensaufnahme |
GB0426264D0 (en) * | 2004-11-30 | 2004-12-29 | Trigen Ltd | Compounds |
JP4556061B2 (en) * | 2006-07-27 | 2010-10-06 | ビーエイチエヌ株式会社 | Hyaluronic acid production enhancer |
CN101396357B (en) * | 2007-09-29 | 2010-12-29 | 中国科学院上海生命科学研究院 | Use of lipoamide in preventing and treating insulin resistance |
US9044439B2 (en) | 2008-03-05 | 2015-06-02 | Encore Health, Llc | Low dose lipoic and pharmaceutical compositions and methods |
WO2009111635A2 (en) | 2008-03-05 | 2009-09-11 | Encore Health, Llc | Dithiol compounds, derivatives, and uses therefor |
EP3069612A3 (en) | 2009-06-15 | 2016-10-19 | Encore Health, LLC | Dithiol compounds, derivatives, and uses therefor |
DK2442645T3 (en) | 2009-06-15 | 2014-11-24 | Encore Health Llc | choline |
CN101671331B (en) * | 2009-09-29 | 2011-06-01 | 寿光富康制药有限公司 | Lipoyl vildagliptin as well as preparation method and application thereof |
JP5245061B2 (en) * | 2010-05-12 | 2013-07-24 | ビーエイチエヌ株式会社 | Oral antioxidant and beauty method |
JP6535013B2 (en) * | 2013-09-19 | 2019-06-26 | ザ・リサーチ・ファウンデーション・フォー・ザ・ステイト・ユニヴァーシティ・オブ・ニューヨーク | Methods and agents for treating diabetes or hepatic steatosis |
WO2015050809A1 (en) * | 2013-10-01 | 2015-04-09 | Novozymes A/S | Processes of producing fermentation products |
KR20160145558A (en) | 2014-03-03 | 2016-12-20 | 앙코르 비전, 인코포레이티드 | Lipoic acid choline ester compositions and methods of use |
AU2016243516A1 (en) | 2015-03-27 | 2017-11-09 | The Research Foundation For The State University Of New York | Methods and materials for reducing amyloid beta levels within a mammal |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4343593C2 (en) * | 1993-12-21 | 1998-05-20 | Asta Medica Ag | Use of R - (+) - alpha-lipoic acid, R - (-) - dihydrolipoic acid or the metabolites as well as their salts, esters, amides for the treatment of compensated and decompensated insulin resistance |
US5962030A (en) * | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
ES2252874T3 (en) * | 1997-12-12 | 2006-05-16 | Purdue Research Foundation | USE OF CONJUGATED LINOLEIC ACID FOR TREATMENT OF MELLITUS TYPE II DIABETES. |
US6440931B1 (en) * | 1999-02-23 | 2002-08-27 | Natural Corporation | Conjugated linoleic acid in treatment and prophylaxis of diabetes |
US6288106B1 (en) * | 1999-05-25 | 2001-09-11 | Chronorx, Llc | Processes for the synthesis and use of various α-lipoic acid complexes |
AU2001234782A1 (en) * | 2000-02-02 | 2001-08-14 | Metagenics, Inc. | Compositions and methods for promoting healthy joints |
-
2000
- 2000-09-12 DE DE10045059A patent/DE10045059A1/en not_active Withdrawn
-
2001
- 2001-09-11 ES ES01963002T patent/ES2225593T3/en not_active Expired - Lifetime
- 2001-09-11 DE DE50103029T patent/DE50103029D1/en not_active Expired - Lifetime
- 2001-09-11 AT AT01963002T patent/ATE271866T1/en active
- 2001-09-11 DK DK01963002T patent/DK1317264T3/en active
- 2001-09-11 JP JP2002526363A patent/JP2004508399A/en active Pending
- 2001-09-11 EP EP01963002A patent/EP1317264B1/en not_active Expired - Lifetime
- 2001-09-11 US US10/363,658 patent/US20030187058A1/en not_active Abandoned
- 2001-09-11 AU AU2001284057A patent/AU2001284057A1/en not_active Abandoned
- 2001-09-11 CN CN018155413A patent/CN1216602C/en not_active Expired - Fee Related
- 2001-09-11 WO PCT/EP2001/010501 patent/WO2002022111A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN1455670A (en) | 2003-11-12 |
EP1317264A2 (en) | 2003-06-11 |
WO2002022111A3 (en) | 2003-02-27 |
EP1317264B1 (en) | 2004-07-28 |
CN1216602C (en) | 2005-08-31 |
ES2225593T3 (en) | 2005-03-16 |
DE50103029D1 (en) | 2004-09-02 |
JP2004508399A (en) | 2004-03-18 |
WO2002022111A2 (en) | 2002-03-21 |
ATE271866T1 (en) | 2004-08-15 |
US20030187058A1 (en) | 2003-10-02 |
DE10045059A1 (en) | 2002-03-21 |
DK1317264T3 (en) | 2004-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001284057A1 (en) | Combination of lipoic acids and conjugated acids for treating diabetic disorders | |
AU2004280090B2 (en) | Dual alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases | |
BR9814484A (en) | "aspartyl protease inhibitor prodrugs" | |
WO2001019776A3 (en) | Novel derivatives of dicarboxylic acid having pharmaceutical properties | |
WO2002062751A1 (en) | Novel cystine derivatives and inhibitors for the activation of inflammatory factors | |
IL148103A0 (en) | Novel dicarboxylic acid derivatives with pharmaceutical properties | |
GEP20032987B (en) | Stabilized Solid Compositions Containing Gamma-Aminobutyric Acid Derivatives for Treatment of Neuropathologic Diseases and Process for Preparing The Same | |
UA74346C2 (en) | Aminodicarboxylic acids derivatives, use thereof and a medicament | |
WO2002055496A8 (en) | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | |
MY139303A (en) | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
EA200500377A1 (en) | PYRAZOL DERIVATIVES AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
ATE375341T1 (en) | THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OR PREVENTION OF PAIN | |
DE60140491D1 (en) | Use of a pharmaceutical composition with a para-aminophenylacetic acid derivative for the treatment of inflammatory diseases of the gastrointestinal tract | |
MD523G2 (en) | New triazol pyrimidine derivatives, angiotension II antagonist, processes for preparation thereof, pharmaceutical compositions containg thereof | |
BG106155A (en) | Novel derivatives and analogues of galanthamin | |
RU94038256A (en) | Derivatives of pyrazolopyrimidine, method of their synthesis, pharmaceutical compositions based on thereof | |
HK1090354A1 (en) | Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof | |
CY1112057T1 (en) | THERAPEUTIC PRODUCTS FOR AUTOMATIC ADMINISTRATION | |
EP1374868A4 (en) | Remedies and/or preventives for diabetic ischemic heart diseases | |
IL131216A (en) | Drugs inhibiting progress of pterygium and postoperative recurrence of the same | |
EP1418910A4 (en) | Methods for inhibiting or reversing tau filament formation polymerization | |
WO2002009717A1 (en) | Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient | |
MY122570A (en) | Benzamide derivatives and drugs containing the same |